Financial
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
HQ United States · North America
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
Products not yet catalogued.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
No adverse media (litigation, regulator action, restructuring or financial distress) involving First Databank found in HSH's search of the last 24 months.
No data breaches, cyber incidents or regulator actions involving First Databank found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
No product recalls, regulator safety notices or clinical safety incidents involving First Databank's medicines knowledge or decision support products found in HSH's search of the last 24 months.
May 2025: First Databank UK won a contract worth up to £1.25m for prescribing decision support software for NHS Derby and Derbyshire ICB (Apr 2025 to Mar 2028); NHS Kent and Medway ICB also contracted it for prescribing decision support from Sep 2025.
No competitors linked yet.